Coronavirus

SARS-CoV-2 research reagents, antiviral screening tools, and immune response assays — supporting the global effort to understand and combat coronaviruses.

Browse Products Back to Field of Research

Supporting Coronavirus & Pandemic Preparedness Research

The COVID-19 pandemic highlighted the critical need for validated research reagents to study emerging infectious diseases. Enzo Life Sciences provides researchers with antibodies targeting SARS-CoV-2 structural and non-structural proteins, ACE2 receptor reagents, antiviral compound screening libraries, and cytokine storm monitoring assays. Our tools support research from viral entry mechanisms through host immune response and therapeutic development.

Coronavirus Research Areas

Key product categories for coronavirus research

SARS-CoV-2 Antibodies

Antibodies targeting spike protein (S1, S2, RBD), nucleocapsid, and non-structural proteins validated for ELISA, Western blot, IHC, and neutralization studies.

ACE2 & Entry Pathway

ACE2 recombinant proteins, antibodies, and cell-based assays for studying viral entry mechanisms, receptor binding, and potential entry-blocking therapeutics.

Antiviral Screening

SCREEN-WELL antiviral compound libraries and individual bioactive molecules for high-throughput screening of potential COVID-19 and pan-coronavirus therapeutics.

Cytokine Storm Monitoring

Severe COVID-19 and other coronavirus infections can trigger a dangerous cytokine storm characterized by elevated IL-6, TNF-α, IL-1β, and other pro-inflammatory mediators. Our validated cytokine ELISA kits enable researchers to monitor the inflammatory cascade in patient samples, animal models, and in vitro infection systems, supporting development of immunomodulatory therapies.

Cytokines

Learn More

Explore Coronavirus Research Tools

Explore our curated product selection for this research area or contact our scientific support team for personalized recommendations.

Browse Coronavirus Products Talk to a Scientist

Search